In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
This is the first update to the original CTS communication distributed on July 6th. As previously co...